Published: Guidance, quality standards and advice
Showing 81 to 86 of 86
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Percutaneous radiofrequency ablation for primary or secondary lung cancers | HTG244 | ||
| Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer | TA192 | ||
| Topotecan for the treatment of relapsed small-cell lung cancer | TA184 | ||
| Pemetrexed for the first-line treatment of non-small-cell lung cancer | TA181 | ||
| Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal) | TA148 | ||
| Pemetrexed for the treatment of non-small-cell lung cancer | TA124 |